Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mukocil is a dietary supplement developed and manufactured by Pharma-Med, primarily available as Mukocil 600. It is a combination product containing N-acetylcysteine (NAC) and propolis extract. N-acetylcysteine functions as a mucolytic agent by reducing the disulfide bonds in respiratory mucoproteins, thereby decreasing the viscosity of mucus and facilitating its clearance from the respiratory tract. Propolis is included for its natural antimicrobial and immune-supportive properties. Mukocil is used for the symptomatic treatment of respiratory conditions characterized by thick, viscous mucus, such as bronchitis, the common cold, and influenza.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Mukocil.